IMImane Motaib

Imane Motaib

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Imane Motaib has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Asmaa Chadli

    Endocrinology, Diabetology, Metabolic Disease, and Nutrition, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR

    5 shared publications
  • Asma Chadli

    Affiliation Department of Endocrinology Diabetology Metabolic Disease and Nutrition, Faculty of Medicine, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco

    4 shared publications
  • Saloua Elamari

    Mohammed VI Univ Hlth Sci UM6SS, Dept Endocrinol Diabetol Metab Dis & Nutr, Casablanca 82403, Morocco

    4 shared publications
  • Soukaina Laidi

    Affiliation Department of Endocrinology Diabetology Metabolic Disease and Nutrition, Faculty of Medicine, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco

    4 shared publications
  • Saloua Elamari

    Mohammed VI Center for Research & Innovation, Rabat, Morocco

    3 shared publications
  • Soukaina Laidi

    Endocrinology, Diabetology, Metabolic Disease, and Nutrition, Mohammed VI University of Health Sciences, Casablanca, MAR

    3 shared publications

Latest Publications

  • Assessing the quality and guideline-concordance of AI-powered chatbots in nutritional management of diabetes

    by Maryame Ben Lafqih, Faiçal Ait Lahbib, Kaltoum Boutahar, Hanane Azargui, Rachid Elfatimy, Imane Motaib


  • Open Access

    Diabetic retinopathy as the primary predictor of mild cognitive impairment in type 2 diabetes: Insights from machine learning models

    by Fatima Zahra Rhmari Tlemçani, Faiçal Aitlahbib, Soukaina Laidi, Najib Alidrissi, Jehanne Aasfara, Saloua Elamari, Asma Chadli, Imane Motaib

    Mild cognitive impairment (MCI) is a significant and increasingly recognized problem in individuals with type 2 diabetes mellitus (T2DM). This study aims to develop a machine-learning model to predict MCI in patients with T2DMThe dataset was obtained from a prospective cohort conducted at the Sheikh Khalifa Ibn Zaid Hospital, Casablanca, Morocco, and was randomly split into three parts. Machine learning models were trained using the training dataset, and their performance was assessed on the test dataset. The unseen data was reserved for final validation. Subsequently, recursive feature elimination was applied with the top two algorithms to identify and retain the most impactful features for predicting MCI. Then, we retrained the models using the selected variables. Finally, the variables most contributing to the prediction of MCI were represented in a Shapley Additive Explanations SHAPE value plot to better understand their contribution and their ranking in MCI prediction.The dataset included 100 patients. Extra Trees classifier was the best-performing model for mild cognitive impairment (Accuracy: 0·9310/AUC: 0·9667/ Recall: 0·9333/ Precision: 0·9333/F1: 0·9333). The most contributing factors to MCI in patients with type 2 diabetes were, respectively, diabetic retinopathy, age, serum LDL cholesterol level, microalbuminuria, HbA1c, and, serum creatinine level. Our findings suggest avenues for early intervention that could prevent the progression of cognitive impairment among patients with type 2 diabetes.


  • Open Access

    Factors Associated With Mild Cognitive Impairment in Patients With Type 2 Diabetes: A Cohort Study

    by Fatima Zahra Rhmari Tlemçani, Saloua Elamari, Imane Motaib, Soukaina Laidi, Najib Alidrissi, Samir Ahid, Asmaa Chadli

    Cognitive dysfunction is increasingly recognized as an important comorbidity of diabetes mellitus (DM). The purpose of this study was to determine the prevalence and predictors of cognitive decline in individuals with type 2 diabetes mellitus (T2DM). This cohort study included patients with type 2 diabetes mellitus aged between 40 and 75 years and with a duration of the evolution of diabetes that is greater than five years admitted in endocrinology consultation of the Sheikh Khalifa ibn Zaid Hospital in Casablanca, Morocco. For each patient, we collected clinical characteristics and biological assessments. All subjects provided screening test results as defined by the Mini-Mental State Examination (MMSE). We included a total of 100 patients with diabetes between May and September 2021. The median age of the patients was 65 years (interquartile range (IQR): 59-70 years), 65% were males, and the median duration of diabetes was 15 years (IQR: 9-20 years). The most common cardiovascular risk factors (CVRFs) were hypertension (72.7%) and dyslipidemia (53%). The most common complications of diabetes were peripheral neuropathy (50%), diabetic retinopathy (DR) (39%), peripheral artery disease (33%), and coronary artery disease (27%). Cognitive impairment was present in 47.5% of our patients. For the multivariate analysis, we found that the decrease in the MMSE score is associated with the increase in age (p-value = 0.004) and the occurrence of diabetic retinopathy (p-value < 0.001), dyslipidemia (p-value = 0.006), and elevated creatinine (p-value < 0.001). It is necessary to consider the cognitive decline of patients with diabetes as one of the most important complications of this disease because of its impact on the evolution and compliance of these patients.


  • Open Access

    Ramadan and Diabetes: What About Non-Fasting Patients with Diabetes?

    by Imane Motaib, Fatima-Zahra Rhmari Tlemçani, Mohamed Khalis, Soukaina Laidi, Saloua Elamari, Asma Chadli

    Background: The management of diabetes during Ramadan is well codified. International guidelines recommend avoiding fasting for patients with the risk of complications. However, during Ramadan drastic changes occur in lifestyles habits. Our study aims to evaluate the impact of the month of Ramadan on the lifestyle habits and metabolic profile of non-fasting patients with diabetes. Patients and Methods: This observational cross-sectional study was carried out during 3 months of Ramadan in 2018, Ramadan 2019, and Ramadan 2021. We conducted 3 consultations (before, during, and after Ramadan). Before Ramadan, we collected anthropometric and metabolic parameters, and we assessed physical activity level and dietary intake. During Ramadan, we evaluated the occurrence of complications such as hyperglycemia and hypoglycemia, as well as we assessed physical activity level, dietary intake, and the number of meals. After Ramadan re-evaluate anthropometric and metabolic parameters. Results: We included 155 patients, 93.5% had type 2 diabetes and 6.5% had type 1 diabetes. We found that glycated hemoglobin, LDL cholesterol, and Triglyceride increased significantly after Ramadan (p-value < 0.001). We also found that weight, body mass index, waist circumference. Caloric intake increased significantly during Ramadan (p-value < 0.001); this increase concerned 61.3% of patients. In terms of metabolic parameters, diabetes was unbalanced in 52.6% of patients, hypoglycemia occurs in 20.9% of patients, and hyperglycemia was experienced by 37% of patients during Ramadan. We found that LDL cholesterol increased in 48.4% of patients, triglycerides increased in 60.6% of patients and serum level of total cholesterol increased in 55% of patients. Conclusion: Our study showed that during Ramadan risk of complications in patients with diabetes is not only related to fasting.

  • Open Access

    TRANSITION IN ENDOCRINOLOGY: WHAT MOROCCAN ENDOCRINOLOGISTS AND PEDIATRICIANS THINK?

    by Meryem Drissi Oudghiri, Imane Motaib, Saloua Elamari, Soukaina Laidi, Asma Chadli

    Background:Transition is defined as the transfer of a patient from a child to an adult structure.Our study aimed to describe and compare the state of knowledge of endocrinologists and pediatricians about the transition period. Methods:This was a prospective cross-sectional study conducted during July 2020. We made two questionnaires. We compared the two groups in terms of: practice area, hospital activity and definition of transition, age of transition in routine practice among endocrinologists and pediatricians, and the existence or not of a transition consultation at the practice area. Results:Sixty percent of endocrinologists received patients referred by pediatricians between the ages of 15 and 18 years old, 20% received patients between the ages of 10 and 15 years old and 20% after 18 years old. The mean age of transition was between 15 and 18 years, according to 67.6% of pediatricians, after 18 years old for 29.4% of pediatricians and between 10 and 15 years old for 2.9% of them. Endocrinologists and pediatricians were comparable in terms of practice area, hospital activity, definition of transition age, the existence of a transition consultation, and also in terms of transition-age in current practice. We found a statistically significant difference in terms of practice area between endocrinologists and pediatricians (p-value: 0.025). Conclusion:Our study highlighted the importance of specific support to facilitate the transfer from pediatric to adult care for young patients.

  • Open Access

    Treatment of Graves' Disease Associated With Severe Neutropenia

    by Soukaina Laidi, Imane Motaib, Saloua Elamari, Said Anajar, Asma Chadli

    Severe neutropenia in newly diagnosed hyperthyroidism is a diagnostic and therapeutic dilemma since antithyroid drugs (ATDs) cannot be started if the absolute neutrophil count (ANC) is 9/L. We report the case of a patient followed for hyperthyroidism associated with severe neutropenia treated with dexamethasone and ATD. The patient was 51 years old and was hospitalized for hyperthyroidism with a thyroid stimulating hormone (TSH) level 9/L. He was put on prednisolone 60 mg/day and propranolol 60 mg/day for three weeks without improvement. Faced with the association of hyperthyroidism and severe neutropenia, we could not start the ATD for fear of agranulocytosis; we put the patient on propranolol 60 mg and dexamethasone 6 mg with progressive degression resulting in a spectacular increase of ANC from 0.4 x 109/L to 7.1 x 109/L, which allowed us to start the ATD (carbimazole) at a dose of 30 mg, and then 50 mg, with monitoring of ANC and transaminases every 48 hours. Euthyroidism was achieved after 15 days. A curative treatment with radioactive iodine ablation was administered. Our patient did not respond to prednisolone but responded dramatically to dexamethasone; this leads us to consider using dexamethasone for the rapid preparation for radical treatment of patients with GD.


  • Open Access

    Pituitary Apoplexy in Geriatric Patients: A Report of Four Cases

    by Meryem Drissi Oudghiri, Imane Motaib, Saloua Elamari, Soukaina Laidi, Asmaa Chadli

    Pituitary apoplexy (PA) is a rare clinical syndrome related to abrupt hemorrhage and/or infarction of the pituitary gland, usually occurring in patients with preexisting pituitary disease. It is an endocrine emergency requiring rapid diagnosis and appropriate management. This is a literature review and a retrospective study reporting the observation of four patients that have suffered from pituitary macroadenomas. These observations illustrate the particularities of this pathology in the elderly. The symptoms may be truncated and lead to a late diagnosis with its repercussions on management, without forgetting the particularity of the fragile and multisystemic terrain, which may contraindicate the usual surgical treatment. A rapid diagnosis and appropriate management can limit the occurrence of irreversible complications.


  • Open Access

    Diabetes During the Fasting Month of Ramadan: Is Telemedicine as Efficient as Conventional Follow-Up? Results from a Moroccan Comparative Study

    by Imane Motaib, Saloua Elamari, Mohamed Khalis, Meryem Drissi Eloudghiri, Soukaina Laidi, Asma Chadli

    Aim: During the COVID-19 pandemic, access to health care was affected by the lockdown period. To overcome this situation, telemedicine is an alternative to conventional follow-up for patients with diabetes during the fasting month of Ramadan. The aim of this study is to compare the effectiveness of telemedicine consultation of diabetic patients during Ramadan compared with conventional follow-up. Methods: This comparative cross-sectional study conducted in the Sheikh Khalifa Ibn Zaid Hospital of Casablanca, Morocco, included diabetic patients followed up by conventional consultation in 2019 Ramadan and by telemedicine in 2020 Ramadan. For each patient and in both Ramadans (2019 and 2020), we have conducted a pre-Ramadan assessment, screening for acute diabetic complications during Ramadan and an evaluation of weight and glycated hemoglobin of patients, after Ramadan. We compared the occurrence of acute complications and the variation of metabolic parameters of patients in Ramadan 2020 with their results in Ramadan 2019. Results: In this study, we included 61 patients. In Ramadan 2020, compared with Ramadan 2019, there was no significant difference in terms of hypoglycemia (18.03% versus 32.78%, p = 0.09), minor hyperglycemia (13.1% versus 11.47%, p = 0.35) and major hyperglycemia or ketoacidosis (3.27% versus 6.55%, p = 0.19). Fasting was interrupted in 8.19% versus 11.47% (p = 0.012). There were no significant variations of weight (+0.62 versus − 0.77; p = 0.09). In term of variation of glycated hemoglobin, there was a significant different between Ramadan 2020 and Ramadan 2019 (− 0.36 versus − 0.61 in 2019, p< 0.05). Conclusion: Despite comparable results in terms of weight change and hypoglycemia, our study showed that telemedicine follow-up in patients with diabetes during Ramadan did not provide as effective glycemic control as conventional monitoring.


  • Open Access

    Cardiovascular Risk Factors and the Severity of COVID-19 Disease

    by Imane Motaib, Saad Zbiri, Saloua Elamari, Amal Haoudar, Asma Chadli, Chafik El Kettani

    Several cardiovascular risk factors have emerged as important determinants of severe illness and death among coronavirus disease 2019 (COVID-19) patients. However, the full impact of these cardiovascular risk factors is still under investigation. This study aimed to investigate the association between patients' level of cardiovascular risk and the severity of COVID-19. This observational study included all adult patients with COVID-19 hospitalized at Sheikh Khalifa Ibn Zaid International University Hospital from March 20 to May 10, 2020. The cardiovascular risk level was assessed by the doctor responsible for each patient based on the 2019 European Society of Cardiology (ESC), the European Atherosclerosis Society (EAS), and the European Association for the Study of Diabetes (EASD) guidelines. We examined the association between the patients' level of cardiovascular risk and their severity of COVID-19 disease by using a logistic regression model. Among 133 patients with confirmed COVID-19, 46.6% had a low cardiovascular risk level, 19.5% had a moderate risk level, 15.8% had a high risk level, and 18.1% was found to have a very high risk level. Patients with different cardiovascular risk levels had significantly different rates of complications including secondary infection (p-value: <0.001), acute respiratory distress syndrome (ARDS) (p-value = 0.017), intensive care unit (ICU) admission (p-value: <0.001), and death (p-value: <0.001). A patient's very high cardiovascular risk level versus low, moderate, or high cardiovascular risk level was independently associated with ICU admission [OR = 6.42, 95% CI: (1.45-28.30)]. Based on our findings, an increased level of cardiovascular risk among patients was strongly associated with the severity of COVID-19. This study also highlights the need for assessing cardiovascular risk factors in all patients with COVID-19.


  • Open Access

    Obesity and Disease Severity Among Patients With COVID-19

    by Imane Motaib, Saad Zbiri, Saloua Elamari, Nezha Dini, Asma Chadli, Chafik El Kettani

    Obesity can be associated with one or more co-morbidities that worsen the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Studies demonstrated that severe forms of coronavirus disease (COVID-19) have occurred in elderly patients and patients with co-morbidities such as diabetes, hypertension, and cardiovascular diseases. This study investigated the impact of obesity on COVID-19 severity, irrespective of other individual factors. This retrospective observational study included all adult patients with confirmed COVID-19 infection, who were admitted to Sheikh Khalifa Ibn Zaid International University Hospital between March 20 and May 10, 2020. First, we compared patients with and those without obesity in terms of demographic characteristics, co-morbidities, clinical symptoms, and outcomes. Further, using logistic regression models, we analyzed the association between obesity and intensive care unit (ICU) admission. Also, we examined whether the association between obesity and ICU admission was also consistent among overweight patients. The study population included 107 patients with confirmed COVID-19 infection. Obese patients have been admitted in ICU more than patients without obesity (P-value = 0.035). While adjusting for other risk factors for ICU admission, we found that obesity was an independent risk factor for ICU admission (OR = 5.04, 95% CI (1.14-22.37)). When we examined the association of both obesity and overweight with ICU admission, we found that only obesity was significantly associated with ICU admission (OR = 9.11, 95% CI (1.49-55.84)). Our study found that obesity was strongly associated with severity of COVID-19. The risk of ICU admission is greater in the presence of obesity. Physicians should be awarded to the need of specific and early management of obese patients with COVID-19 disease.